Suppr超能文献

携带腹水瘤AH 13、AH 66和AH 414以及3-甲基胆蒽诱导肿瘤的大鼠肝脏中δ-氨基乙酰丙酸合成酶、血红素加氧酶、微粒体细胞色素含量及药物代谢的变化

Alterations of hepatic delta-aminolevulinic acid synthetase, heme oxygenase, microsomal cytochrome content and drug metabolism in rats bearing ascitic tumors AH 13, AH 66 and AH 414 and a 3-methylcholanthrene induced tumor.

作者信息

Matsuura Y, Watanabe H, Fukuda T, Yoshida T, Kuroiwa Y

出版信息

J Pharmacobiodyn. 1984 Jul;7(7):501-10. doi: 10.1248/bpb1978.7.501.

Abstract

Hepatic microsomal drug-metabolizing enzyme activities, cytochrome content, delta-aminolevulinic acid (ALA) synthetase and heme oxygenase activities were studied in rats bearing ascitic tumors AH 13, AH 66 and AH 414 and a primary, 3-methylcholanthrene (3-MC)-induced, tumor. Hepatic microsomal drug-metabolizing enzyme activities and cytochrome content were decreased in rats transplanted intraperitoneally with 1-2 x 10(6) cells of ascitic tumor cell lines AH 13, AH 66 and AH 414. The extent of the decrease of the microsomal cytochrome content and enzyme activities were dependent on the tumor-bearing periods after inoculation. Hepatic microsomal heme oxygenase activity was significantly increased concurrently with the decrease of microsomal drug-metabolizing enzyme activities and cytochrome content. Hepatic ALA synthetase was not changed appreciably in these tumor-bearing rats. Similar alterations of microsomal enzyme content and activities were observed in the livers of rats transplanted subcutaneously with AH 66 tumor cells and in rats bearing a primary tumor initiated by the subcutaneous injection of 3-MC. When the tumor was surgically removed from the rats bearing AH 66 subcutaneously, these hepatic microsomal parameters returned to normal levels. Microsomal drug-metabolizing enzyme activities and cytochrome content in these ascitic tumor cells were found to be at very low levels. From these results, if appears that there is an inverse relationship between the increase of microsomal heme oxygenase activity and the decrease of cytochrome P-450 and b5 as well as drug-metabolizing enzymes in the liver of tumor bearing rats.

摘要

在患有腹水瘤AH 13、AH 66和AH 414以及原发性3-甲基胆蒽(3-MC)诱导肿瘤的大鼠中,研究了肝微粒体药物代谢酶活性、细胞色素含量、δ-氨基乙酰丙酸(ALA)合成酶和血红素加氧酶活性。腹腔内移植1-2×10⁶个腹水瘤细胞系AH 13、AH 66和AH 414的大鼠,其肝微粒体药物代谢酶活性和细胞色素含量降低。微粒体细胞色素含量和酶活性的降低程度取决于接种后的荷瘤时间。肝微粒体血红素加氧酶活性在微粒体药物代谢酶活性和细胞色素含量降低的同时显著增加。在这些荷瘤大鼠中,肝ALA合成酶没有明显变化。在皮下移植AH 66肿瘤细胞的大鼠肝脏以及皮下注射3-MC引发原发性肿瘤的大鼠肝脏中,观察到了微粒体酶含量和活性的类似变化。当从皮下接种AH 66的大鼠身上手术切除肿瘤后,这些肝微粒体参数恢复到正常水平。发现这些腹水瘤细胞中的微粒体药物代谢酶活性和细胞色素含量处于非常低的水平。从这些结果来看,荷瘤大鼠肝脏中微粒体血红素加氧酶活性的增加与细胞色素P-450和b5以及药物代谢酶的降低之间似乎存在负相关关系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验